SB-225002

CAS No. 182498-32-4

SB-225002( SB225002 )

Catalog No. M12815 CAS No. 182498-32-4

A potent, selective non-peptide CXCR2 antagonist with IC50 of 22 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 39 In Stock
10MG 55 In Stock
25MG 116 In Stock
50MG 213 In Stock
100MG 383 In Stock
200MG 584 In Stock
500MG 888 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SB-225002
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective non-peptide CXCR2 antagonist with IC50 of 22 nM.
  • Description
    A potent, selective non-peptide CXCR2 antagonist with IC50 of 22 nM; displays >150-fold selectivity over CXCR1; potently inhibits human and rabbit neutrophil chemotaxis induced by both IL-8 and GROalpha in vitro; selectively blocks IL-8-induced neutrophil margination in rabbits.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SB225002
  • Pathway
    GPCR/G Protein
  • Target
    Chemokine Receptor
  • Recptor
    CXCR2
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    182498-32-4
  • Formula Weight
    352.1402
  • Molecular Formula
    C13H10BrN3O4
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(NC1=CC=C([N+]([O-])=O)C=C1O)NC2=CC=CC=C2Br
  • Chemical Name
    Urea, N-(2-bromophenyl)-N'-(2-hydroxy-4-nitrophenyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. White JR, et al. J Biol Chem. 1998 Apr 24;273(17):10095-8. 2. Auten RL, et al. J Pharmacol Exp Ther. 2001 Oct;299(1):90-5. 3. Manjavachi MN, et al. Eur J Pain. 2010 Jan;14(1):23-31.
molnova catalog
related products
  • SCH-546738

    SCH-546738 (SCH546738) is a potent, selective and non-competitive CXCR3 antagonist with binding Ki of 0.4 nM for human CXCR3.

  • INCB-3344

    A potent, selective and orally bioavailable CCR2 antagonist with IC50 of 5.1 nM and 9.5 nM for hCCR2 and mCCR2, respectively.

  • GSK-2239633

    GSK-2239633 is a potent, selective, allosteric CCR4 antagonist with pIC50 of 7.96.